Intel Corp.

The stock is in a powerful multi-month recovery, trading well above its 200-day average and not far from its 52-week high after a deep prior-year washout. That keeps the regime constructive, though the move has already reset expectations and leaves room for volatility after a sharp run.

Street sentiment is cautious-to-balanced: consensus sits at Hold, while the average target of about $98 is below the recent trading level. Recent changes have been mixed, with several firms lifting targets sharply and a few downgrades, signaling improving fundamental confidence but no clean unanimous call.

The next print has a favorable beat backdrop, with Intel beating EPS in 5 of the last 7 quarters. Estimates point to a sharp step-up in 2027 EPS versus the current TTM loss, so shareholders should watch whether margin repair and foundry execution keep that trajectory intact.

Recent activity skews to net selling, but most of the tape is award, vesting, and exempt-share movement rather than discretionary conviction. The only clear open-market sale was 21,024 shares by the Foundry operations chief, while the CFO’s activity was tied to exempt and in-kind items.

Profitability is still uneven, but the operating line is back in positive territory with a 6.88% operating margin and 7.2% revenue growth year over year. Cash generation is solid, with $9.697 billion of operating cash flow and $24.343 billion of free cash flow, though leverage remains meaningful with $46.585 billion of debt.

Intel still trades like a turnaround name versus peers: the market is paying for recovery, not current earnings power, with a 193.67 P/E against a sector that typically values steadier margin profiles more richly only when growth is durable. The setup favors investors who want foundry and AI execution upside over near-term consistency.